• Feb 20, 2025

Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $167.5 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $697.5 million at the midpoint. Its non-GAAP profit of $0.44 per share was 7.9% above analysts’ consensus estimates.

  • Feb 20, 2025

Baxter (NYSE:BAX) Beats Q4 Sales Targets, Stock Soars

Healthcare company Baxter International (NYSE:BAX) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $2.75 billion. On the other hand, next quarter’s revenue guidance of $2.58 billion was less impressive, coming in 1.4% below analysts’ estimates. Its non-GAAP profit of $1.89 per share was significantly above analysts’ consensus estimates.

  • Feb 20, 2025

3 Industrials Stocks in the Penalty Box

Even if they go mostly unnoticed, industrial businesses are the backbone of our country. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the industry has underperformed the market over the past six months as its 7.2% return lagged the S&P 500 by 2.3 percentage points.

  • Feb 20, 2025

2 Industrials Stocks Primed for Growth and 1 to Snub

Whether you see them or not, industrials businesses play a crucial part in our daily activities. Unfortunately, this role also comes with a demand profile tethered to the ebbs and flows of the broader economy, and the industry is currently lagging as its six-month return of 7.2% has trailed the S&P 500’s 9.5% gain.

  • Feb 20, 2025

3 Consumer Stocks to Axe From Your List

Most consumer discretionary businesses succeed or fail based on the broader economy. This volatility leads to big swings in stock prices that have worked in their favor recently - over the past six months, the industry has returned 16.4% and beat the S&P 500 by 7 percentage points.

  • Feb 20, 2025

Builders FirstSource (NYSE:BLDR) Misses Q4 Revenue Estimates, Stock Drops

Building materials company Builders FirstSource (NYSE:BLDR) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 8% year on year to $3.82 billion. The company’s full-year revenue guidance of $17 billion at the midpoint came in 1.7% below analysts’ estimates. Its non-GAAP profit of $2.31 per share was 4% above analysts’ consensus estimates.

  • Feb 20, 2025

BigCommerce (NASDAQ:BIGC) Reports Q4 In Line With Expectations But Full-Year Sales Guidance Slightly Misses Expectations

E-commerce software platform provider BigCommerce (NASDAQ: BIGC) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 3.4% year on year to $87.03 million. On the other hand, next quarter’s revenue guidance of $82.2 million was less impressive, coming in 1.8% below analysts’ estimates. Its non-GAAP profit of $0.11 per share was 65.7% above analysts’ consensus estimates.

  • Feb 20, 2025

Bandwidth’s (NASDAQ:BAND) Q4 Sales Top Estimates But Stock Drops 11.7%

Communications platform-as-a-service company Bandwidth (NASDAQ: BAND) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 27% year on year to $210 million. On the other hand, next quarter’s revenue guidance of $169 million was less impressive, coming in 8.1% below analysts’ estimates. Its non-GAAP loss of $0.06 per share was significantly below analysts’ consensus estimates.